Exodus Point Capital Management, LP Black Diamond Therapeutics, Inc. Transaction History
Exodus Point Capital Management, LP
- $14.7 Billion
- Q2 2024
A detailed history of Exodus Point Capital Management, LP transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 588,628 shares of BDTX stock, worth $1.76 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
588,628
Previous 115,576
409.3%
Holding current value
$1.76 Million
Previous $586,000
368.09%
% of portfolio
0.02%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BDTX
# of Institutions
102Shares Held
47.2MCall Options Held
108KPut Options Held
24.8K-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.7MShares$31.9 Million0.03% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.52MShares$25.5 Million0.66% of portfolio
-
Nea Management Company, LLC Timonium, MD4.45MShares$13.3 Million1.96% of portfolio
-
Black Rock Inc. New York, NY3.22MShares$9.62 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.13MShares$6.37 Million0.0% of portfolio
About Black Diamond Therapeutics, Inc.
- Ticker BDTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,339,500
- Market Cap $109M
- Description
- Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...